HBV Citations List: October 2023

Literature Citations

1. Synthesis and Evaluation of Highly Potent HBV Capsid Assembly Modulators (CAMs). Amblard, F., Z. Chen, J. Wiseman, S. Zhou, P. Liu, M. Salman, K. Verma, N. Azadi, J. Downs-Bowen, S. Tao, A. Kumari, Q. Zhang, D.B. Smith, D. Patel, L. Bassit, and R.F. Schinazi. Bioorganic Chemistry, 2023. 141: 106923. PMID[37871391].
[PubMed]. HBV_10_2023.

2. Design, Synthesis, and Structure-Activity Relationship of a Bicyclic HBV Capsid Assembly Modulator Chemotype Leading to the Identification of Clinical Candidate AB-506. Cole, A.G., S.G. Kultgen, N. Mani, J.G. Quintero, K. Yi Fan, A. Ardzinski, K. Stever, B.D. Dorsey, J.R. Phelps, A.C.H. Lee, E.P. Thi, T. Chiu, S. Tang, P.S. Horanyi, S.J. Mayclin, T.O. Harasym, and M.J. Sofia. Bioorganic & Medicinal Chemistry Letters, 2023. 94: 129456. PMID[37633618].
[PubMed]. HBV_10_2023.

3. Discovery of 4,5,6,7-Tetrahydropyrazolo[1.5-a]pyrizine Derivatives as Core Protein Allosteric Modulators (CpAMs) for the Inhibition of Hepatitis B Virus. Kou, B., Z. Zhang, X. Han, Z. Zhou, Z. Xu, X. Zhou, F. Shen, Y. Zhou, X. Tian, G. Yang, J.A.T. Young, H. Qiu, G. Ottaviani, A. Mayweg, W. Zhu, H.C. Shen, H. Liu, and T. Hu. Journal of Medicinal Chemistry, 2023. 66(20): p. 14116-14132. PMID[37801325].
[PubMed]. HBV_10_2023.

4. Efficacy of HBV-TCR T Cell Therapy to Eliminate Circulating HBV-HCC Cells in Immunosuppressed Whole Blood. Lin, M.Y., S.C. Bhakdi, D. Tan, A. Pavesi, J. Lee, D. Tai, A. Bertoletti, and A. Tan. Journal of Hepatology, 2023. 78: p. S543-S543. ISI[001037135102095].
[WOS]. HBV_10_2023.

5. Structural and Synthetic Aspects of Small Ring Oxa- and Aza-heterocyclic Ring Systems as Antiviral Activities. Manna, S., K. Das, S. Santra, E.V. Nosova, G.V. Zyryanov, and S. Halder. Viruses, 2023. 15(9): 1826. PMID[37766233]. PMCID[PMC10536032].
[PubMed]. HBV_10_2023.

6. New Oligonucleotide 2'-O-Alkyl N3'→P5' (Thio)-phosphoramidates as Potent Antisense Agents: Physicochemical Properties and Biological Activity. Martínez-Montero, S., V.K. Rajwanshi, R.K. Pandey, N.T.S. De Costa, J. Hong, L. Beigelman, S.M. Gryaznov, and S. Pourshahian. Nucleic Acid Therapeutics, 2023. 33(5): p. 319-328. PMID[37638793].
[PubMed]. HBV_10_2023.

7. Trim26 Positively Affects Hepatitis B Virus Replication by Inhibiting Proteasome-dependent Degradation of Viral Core Protein. Nakaya, Y., T. Nishizawa, H. Nishitsuji, H. Morita, T. Yamagata, D. Onomura, and K. Murata. Scientific Reports, 2023. 13(1): 13584. PMID[37604854]. PMCID[PMC10442393].
[PubMed]. HBV_10_2023.

8. Selective Inhibition of Hepatitis B Virus Internalization by Oxysterol Derivatives. Oshima, M., F. Stappenbeck, H. Ohashi, M. Iwamoto, K. Fukano, A. Kusunoki, X. Zheng, F. Wang, R. Morishita, H. Aizaki, R. Suzuki, M. Muramatsu, K. Kuramochi, C. Sureau, F. Parhami, and K. Watashi. Biochemical and Biophysical Research Communications, 2023. 675: p. 139-145. PMID[37473528].
[PubMed]. HBV_10_2023.

9. Structural Insights into Modeling of Hepatitis B Virus Reverse Transcriptase and Identification of Its Inhibitors from Potential Medicinal Plants of Western Ghats: An in Silico and In vitro Study. Patil, V.S., D.R. Harish, R. Charla, U. Vetrivel, S.S. Jalalpure, V.V. Bhandare, S.H. Deshpande, H.V. Hegde, and S. Roy. Journal of Biomolecular Structure and Dynamics, 2023: p. 1-19. PMID[37811543].
[PubMed]. HBV_10_2023.

10. A Novel Class of Orally-available Small Molecules Potently Inhibiting Hepatitis B and D Virus Entry. Unchwaniwala, N., H. Contreras, J.C. Li, D. Azimova, J. Tan, L. Guo, F.T.G. de Sousa, K. Stray, M. Shen, J.X. Yu, M.P. Windisch, M. Perron, M.A. Walker, W.E. Delaney, and M. Zhong. Journal of Hepatology, 2023. 78: p. S1167-S1167. ISI[001037135105132].
[WOS]. HBV_10_2023.

11. Synthesis of 1,2,3-Triazole-Linked Hexopyranosylpyrimidine Nucleosides and Their Application as Hepatitis B Viral DNA, HBsAg and HBeAg Suppressants. Verma, V., A. Singh, P. Tyagi, V. Kumar, and A.K. Prasad. ChemistrySelect, 2023. 8(12): e202204982. ISI[001061338500042].
[WOS]. HBV_10_2023.

12. Design, Synthesis, and Biological Evaluation of Novel Thioureidobenzamide (TBA) Derivatives as HBV Capsid Assembly Modulators. Wang, M., J. Zhang, Y. Dou, M. Liang, Y. Xie, P. Xue, L. Liu, C. Li, Y. Wang, F. Tao, X. Zhang, H. Hu, K. Feng, L. Zhang, Z. Wu, Y. Chen, P. Zhan, and H. Jia. Journal of Medicinal Chemistry, 2023. 66(20): p. 13968-13990. PMID[37839070].
[PubMed]. HBV_10_2023.

13. AHB-137, a Novel Hepatitis B Virus Antisense Oligonucleotide with Substantially Enhanced in Vitro and in Vivo Antiviral Activity. Wu, X.L., T.T. Lu, W.G. Zhang, Y. Bai, L.Q. Zhang, S.Y. Ma, Y. Chang, J.H. Lei, C.X. Li, Y.Y. Liu, Z.L. Pan, W. Peng, C. Shen, Y.P. Wang, Q.B. Xing, L.S. Zhang, X. Zhou, Y. Tian, C. Yang, and G.F. Cheng. Journal of Hepatology, 2023. 78: p. S1152-S1153. ISI[001037135105110].
[WOS]. HBV_10_2023.

14. Traditional Chinese Medicine Invigorating the Spleen and Kidney Promotes HBsAg Seroclearance in the Mouse Model. Zeng, D.Y., Z. Chen, M.Z. Hong, L.P. Jiang, X.N. Chen, H.X. Xue, J.S. Pan, and Y. Zhu. Journal of Medical Virology, 2023. 95(8): e28979. PMID[37522253].
[PubMed]. HBV_10_2023.

Patent Citations

15. Bicyclic Compounds as Antiviral Agents and Their Preparation. Vendeville, S., D. McGowan, Y. Debing, and P.J.-M.B. Raboisson. Patent. 2023. WO2023-US65907 2023205653: 174 pp.
[Patent]. HBV_10_2023.